Next Article in Journal
Virtual Screening: A Fast Tool for Drug Design
Previous Article in Journal
Effects of Ethanol or Naltrexone after Ethanol Exposure on Plasma Levels of Hepatic Enzymes, Lipid Profile and Apolipoprotein in Rats
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 76
Issue 2
10.3797/scipharm.aut-08-02
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Introduction

Instructions for Authors 2008

by
Scientia Pharmaceutica
Department of Pharmacognosy, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria
Sci. Pharm. 2008, 76(2), 321-332; https://doi.org/10.3797/scipharm.aut-08-02
Submission received: 31 May 2008 / Accepted: 31 May 2008 / Published: 31 May 2008
Versions Notes

Abstract

No abstract available

Share and Cite

MDPI and ACS Style

Pharmaceutica, S. Instructions for Authors 2008. Sci. Pharm. 2008, 76, 321-332. https://doi.org/10.3797/scipharm.aut-08-02

AMA Style

Pharmaceutica S. Instructions for Authors 2008. Scientia Pharmaceutica. 2008; 76(2):321-332. https://doi.org/10.3797/scipharm.aut-08-02

Chicago/Turabian Style

Pharmaceutica, Scientia. 2008. "Instructions for Authors 2008" Scientia Pharmaceutica 76, no. 2: 321-332. https://doi.org/10.3797/scipharm.aut-08-02

Article Metrics

Back to TopTop